Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial

Anthony Rodgers*, Abdul Salam, Aletta E. Schutte, William C. Cushman, H. Asita de Silva, Gian Luca Di Tanna, Diederick E. Grobbee, Krzysztof Narkiewicz, Dike B. Ojji, Neil R. Poulter, Markus P. Schlaich, Suzanne Oparil, Wilko Spiering, Bryan Williams, Jackson T. Wright, P. Lakshman, W. Uluwattage, P. Hay, T. Pereira, N. AmarasenaG. Ranasinghe, Chris Gianacas, Mathangi Shanthakumar, Xiaoqiu Liu, Nelson Wang, Sonali R. Gnanenthiran, Paul K. Whelton,

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science